| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
CD155 in tumor progression and targeted therapy
|
Zhan, Meixiao
|
|
|
545 |
C |
p.
|
artikel
|
| 2 |
Colorectal cancer immunotherapy-Recent progress and future directions
|
Zhao, Wen
|
|
|
545 |
C |
p.
|
artikel
|
| 3 |
Corrigendum to “ebv-circRPMS1 promotes the progression of EBV-associated gastric carcinoma via Sam68-dependent activation of METTL3 [Cancer Letters 535 (2022) 215646]’’
|
Zhang, Jing-yue
|
|
|
545 |
C |
p.
|
artikel
|
| 4 |
Corrigendum to “LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9” [Canc. Lett. 410 (2017) 68–81]
|
Fu, Zhiqiang
|
|
|
545 |
C |
p.
|
artikel
|
| 5 |
Corrigendum to “LncTIC1 interacts with β-catenin to drive liver TIC self-renewal and liver tumorigenesis” [Cancer Lett. 430 (2018) 88–96]
|
Chen, Zhenzhen
|
|
|
545 |
C |
p.
|
artikel
|
| 6 |
Corrigendum to “Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases cell invasion by regulating E-cadherin in a TNFRSF10A-related manner” [Canc. Lett. 371 (2016) 354–365]
|
Zheng, Shangyou
|
|
|
545 |
C |
p.
|
artikel
|
| 7 |
Disruption of enhancer-driven S100A14 expression promotes esophageal carcinogenesis
|
Li, Xukun
|
|
|
545 |
C |
p.
|
artikel
|
| 8 |
Docetaxel resistance-derived LINC01085 contributes to the immunotherapy of hormone-independent prostate cancer by activating the STING/MAVS signaling pathway
|
Zhang, Jiwei
|
|
|
545 |
C |
p.
|
artikel
|
| 9 |
Editorial Board
|
|
|
|
545 |
C |
p.
|
artikel
|
| 10 |
Gastric cancer cell-derived extracellular vesicles disrupt endothelial integrity and promote metastasis
|
Wang, Min
|
|
|
545 |
C |
p.
|
artikel
|
| 11 |
Intratumoral xenogeneic tissue-specific cell immunotherapy inhibits tumor growth by increasing antitumor immunity in murine triple negative breast and pancreatic tumor models
|
Huang, Chi-Ping
|
|
|
545 |
C |
p.
|
artikel
|
| 12 |
Melanoma-derived small extracellular vesicles remodel the systemic onco-immunity via disrupting hematopoietic stem cell proliferation and differentiation
|
Du, Zhimin
|
|
|
545 |
C |
p.
|
artikel
|
| 13 |
PAK4 in cancer development: Emerging player and therapeutic opportunities
|
Yuan, Yixi
|
|
|
545 |
C |
p.
|
artikel
|
| 14 |
PARP inhibitor plus radiotherapy reshapes an inflamed tumor microenvironment that sensitizes small cell lung cancer to the anti-PD-1 immunotherapy
|
Zhang, Nannan
|
|
|
545 |
C |
p.
|
artikel
|
| 15 |
PPAR agonists attenuate lenalidomide's anti-myeloma activity in vitro and in vivo
|
Sha, Yonggang
|
|
|
545 |
C |
p.
|
artikel
|
| 16 |
Predictive biomarkers for personalized medicine in breast cancer
|
Rodrigues-Ferreira, Sylvie
|
|
|
545 |
C |
p.
|
artikel
|
| 17 |
Single cell RNA-seq reveals the CCL5/SDC1 receptor-ligand interaction between T cells and tumor cells in pancreatic cancer
|
Chen, Kai
|
|
|
545 |
C |
p.
|
artikel
|
| 18 |
Vimentin binds to a novel tumor suppressor protein, GSPT1-238aa, encoded by circGSPT1 with a selective encoding priority to halt autophagy in gastric carcinoma
|
Hu, Fan
|
|
|
545 |
C |
p.
|
artikel
|
Tijdschrift beschrijving